Femasys (FEMY) Other Non Operating Income (2020 - 2025)

Femasys (FEMY) reported Other Non Operating Income of -$260000.0 for Q2 2025, down 131.65% quarter-over-quarter from $821515.0 in Q2 2021.

Femasys (FEMY) Other Non Operating Income (2020 - 2025) Analysis & Trends

Femasys has reported Other Non Operating Income for 3 years, with the latest figure at -$260000.0 in Q2 2025.

For the quarter ending Q2 2025, Other Non Operating Income changed N/A year-over-year to -$260000.0; the trailing twelve-month figure through Jun 2025 stood at -$260000.0 (changed N/A YoY), and the FY2025 full-year result was -$482562.0, changed N/A from the prior year.
Other Non Operating Income for Q2 2025 stood at -$260000.0, down from $821515.0 in the prior quarter.
The five-year high for Other Non Operating Income was $821515.0 in Q2 2021, with the low at -$260000.0 in Q2 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Intuitive Surgical	148.09 Bn	143.69 Bn	1.83 Bn
2	Becton Dickinson	41.00 Bn	39.99 Bn	2.15 Bn
3	Medline	30.38 Bn	36.22 Bn	1.84 Bn
4	Resmed	28.22 Bn	26.56 Bn	890.98 Mn
5	West Pharmaceutical Services	23.72 Bn	23.19 Bn	296.40 Mn
6	Solventum	13.33 Bn	13.33 Bn	1.10 Bn
7	Cooper Companies	13.12 Bn	12.99 Bn	735.40 Mn
8	Align Technology	12.86 Bn	11.80 Bn	736.59 Mn
9	Baxter International	10.51 Bn	8.47 Bn	891.00 Mn
10	Femasys	254.59 Mn	249.20 Mn	-

Download Data